News | Proton Therapy | May 10, 2019

IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium

Research agreement with university and industry partners aims to accelerate adoption of proton therapy through new developments in machine learning, statistics and pattern analysis

IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium

May 10, 2019 — IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain and Telemis aimed at accelerating installation, optimizing service and improving clinical operations for proton therapy.

New developments in machine learning, statistics and pattern analysis now allow vendors to provide clinical and operations staff with meaningful outcomes from the data generated by proton therapy systems.

The main objective of this program is to further improve treatment quality through personalized online adaptive therapy. Additionally, this project will also help to maximize the uptime and the patient throughput of the system while minimizing yearly maintenance cost.

The Walloon Region of Belgium supports this three-year agreement, called the BiDMed project (Big Data in Medicine) through its Biowin health cluster.

Alexandru Dasu, medical physicist, chief of physics, Skandionkliniken, commented, “In order to maximize the benefits of proton therapy, we need to minimize the exposure of healthy tissue to the radiation dose. This pushes us to adapt our dose distribution plan as the tumor evolves throughout the course of treatment. This agreement will allow Skandionkliniken to continue to pioneer new ways of using the latest treatment course data to personalize treatment.”

Benoit Macq, Ph.D., UCL, commented, “UCLouvain is proud to be part of this venture. Our university wants to be a key partner in the digital transition of companies with a focus on the use of emerging tools of machine learning. The challenges proposed in BidMed will allow broadening our expertise in deep learning and cyberphysics. BidMed will treat large data sets and will be an exemplary use case of our research in algorithmic.”

Sylvie Ponchaut, managing director Biowin, commented, “BioWin is proud to enrich its portfolio with BidMed, this collaborative and innovative program gathering leaders in the field of proton therapy and digital technologies. By joining our forces in improving personalized cancer treatment, these actors are responding to an important need of the patient and contribute to the reinforcement of the excellence of Wallonia.”

For more information: www.iba-worldwide.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Artificial Intelligence | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging,...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...